Compassion-based family program for adolescents with depression or anxiety

Compassion-Based Family Intervention for Adolescents With Emotional Disorders and Their Parents: A Randomized Waitlist-Controlled Trial

NA · Beijing HuiLongGuan Hospital · NCT07138417

This study tests a six-week compassion-based family program to see if it helps adolescents (ages 12–18) with depression or anxiety and their parents.

Quick facts

PhaseNA
Study typeInterventional
Enrollment60 (estimated)
Ages12 Years to 18 Years
SexAll
SponsorBeijing HuiLongGuan Hospital (other)
Locations1 site (Hefei, Anhui)
Trial IDNCT07138417 on ClinicalTrials.gov

What this trial studies

This is a randomized, waitlist-controlled trial enrolling 60 parent–adolescent dyads at the Fourth People's Hospital of Hefei. Dyads are randomly assigned to immediate intervention or a six-week waiting list, with the intervention delivered in six weekly 120-minute sessions plus daily home practice. Outcomes include self-report measures of symptoms, parenting stress, and family relationships, alongside physiological measures of parent–child synchrony using fNIRS and heart rate monitors. Assessments occur at baseline, post-intervention, and at 3- and 6-month follow-ups, with outcome assessors and data analysts blinded to allocation.

Who should consider this trial

Good fit: Adolescents aged 12–18 with moderate depressive or anxiety symptoms (HAMD-17 score 17–30 or HAMA score 18–29) and at least one parent willing to participate are ideal candidates.

Not a fit: Individuals with psychosis, bipolar disorder, severe neurological or physical disease, substance abuse history, or parents with active mental illness are unlikely to benefit or be eligible for this program.

Why it matters

Potential benefit: If successful, the program could reduce adolescent depression and anxiety symptoms, lower parenting stress, and improve family relationships and physiological emotional synchrony.

How similar studies have performed: Compassion-focused and family-based interventions have shown benefit for adolescent anxiety and depression in prior work, but combining a family compassion program with fNIRS and heart-rate synchrony measures is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* the adolescent is aged 12-18 years
* for the adolescent, required scores at enrollment: at least one of the following criteria is met (i) 17-item Hamilton Depression Rating Scale (HAMD-17) (Hamilton, 1960) total score ≥17 and ≤30, (ii) Hamilton Anxiety Rating Scale (HAMA) (Hamilton, 1959) total score ≥18 and ≤29; and in addition, the item 3 score of HAMD-17 (suicide) must be ≤2
* at least one parent is willing to participate
* the adolescent has normal auditory and visual perception abilities and intellectual level
* the participating parent has normal reading and writing ability
* the adolescent has no history of manic episodes

Exclusion Criteria:

* the adolescent presents with psychotic symptoms, bipolar disorder, or schizophrenia
* the parent suffers from a mental illness or psychological disorder
* the adolescent or their parent has a history of substance abuse
* the adolescent or their parent has a severe neurological disorder or major physical disease
* the adolescent or their parent is assessed as having high suicide risk

Where this trial is running

Hefei, Anhui

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Emotional Disorder, Emotional disorder, adolescents, compassion, parents

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.